Acquisition Backdrop Eye Care and Cure is now part of Hilco Vision since late 2018, following a sequence of acquisitions. This ownership history suggests a potential preference for established distribution channels, possible access to broader product lines, and aligned sales strategies that can be leveraged for cross-selling ophthalmic supplies and related accessories.

Growth Opportunity Revenue is in the low single to mid-range bracket ($1M-$10M) with a small-to-mid employee base. This indicates room for accelerated selling through expanded product catalogs, enhanced procurement programs, and targeted campaigns to dental and optometry practices seeking reliable ophthalmic supply partners.

Product Expansion The company emphasizes innovation and a complete ophthalmic supply portfolio, including pharmaceuticals and surgical supplies, plus a history of launching new lines like EpiGlare. This signals openness to new device integrations, testing equipment, and scalable accessories that complement existing product lines.

Digital Presence Current tech stack includes WordPress and standard web tooling with ecommerce capabilities. There is potential to optimize digital storefronts for upselling, improve content for procurement teams, and deploy targeted digital marketing to ophthalmology clinics and chain practices.

Market Positioning Similar companies vary in size but many operate with larger teams and higher revenues, suggesting Eye Care and Cure could pursue partnerships or distributors that serve mid-market clinics, ambulatory surgical centers, and regional eye care groups to expand reach and recurring purchasing contracts.